A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer
Clinical trial NCT02499497 · COMPLETED
Trial details
- NCT number
- NCT02499497
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-29
- Primary completion
- 2020-10-31
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.